Search Login Register

Naltrexone (ReVia) Summary

Description: Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.

Also Known As: ReVia; Antaxone; Bristol-Myers Squibb Brand of Naltrexone Hydrochloride; Celupan; Du Pont Brand of Naltrexone Hydrochloride Show All >>

Networked: 1331 relevant articles (169 outcomes, 255 trials/studies) for this Drug

Key Diseases for which Naltrexone is Relevant

  1. Alcoholism (Alcohol Abuse) : 38 outcomes 45 studies in 202 results
  2. Pruritus (Itching) : 15 outcomes 10 studies in 47 results
  3. Pain (Aches) : 10 outcomes 15 studies in 81 results
  4. Opioid-Related Disorders (Opiate Addiction) : 10 outcomes 11 studies in 74 results
  5. Obesity : 7 outcomes 9 studies in 50 results
Show All >>

Drugs Related to Naltrexone

  1. Opioid Receptors (Opioid Receptor)
  2. Naltrexone (ReVia)
  3. Morphine (MS Contin)
  4. Naloxone (Narcan)
  5. Bupropion (Wellbutrin)
  6. acamprosate (AOTA)
  7. Opioid Analgesics (Opioids)
  8. Fluoxetine (Prozac)
  9. Ethanol (Ethyl Alcohol)
  10. naltrexone combination morphine
Show All >>

Therapies Related to Naltrexone

  1. Drug Therapy (Chemotherapy)
  2. Injections
  3. Analgesia
  4. Therapeutics
  5. Anesthesia
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.